Literature DB >> 28947939

Synthesis and Investigation of S-Substituted 2-Mercaptobenzoimidazoles as Inhibitors of Hedgehog Signaling.

Simone Gräßle1, Steven Susanto1, Sonja Sievers2, Emel Tavsan1, Martin Nieger3, Nicole Jung1,4, Stefan Bräse1,4.   

Abstract

Due to the arising resistance of common drugs targeting the Hedgehog signaling pathway, the identification of new compound classes with inhibitory effect is urgently needed. We were able to identify S-alkylated 2-mercaptobenzoimidazoles as a new compound class that exhibits Hedgehog signaling activity in a low micromolar range. The scope of the 2-mercaptobenzoimidazole motif has been investigated by the syntheses of diverse derivatives, revealing that the elongation of the linker unit and the exchange of particular substitution patterns are tolerable with respect to the activity of the compound class.

Entities:  

Keywords:  2-mercaptobenzoimidazoles; Hedgehog signaling; cancer; small molecules

Year:  2017        PMID: 28947939      PMCID: PMC5601384          DOI: 10.1021/acsmedchemlett.7b00100

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  29 in total

1.  A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells.

Authors:  Xu Wu; Sheng Ding; Qiang Ding; Nathanael S Gray; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2002-12-11       Impact factor: 15.419

Review 2.  Targeting Hedgehog--a cancer stem cell pathway.

Authors:  Akil A Merchant; William Matsui
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 3.  Mechanisms and functions of Hedgehog signalling across the metazoa.

Authors:  Philip W Ingham; Yoshiro Nakano; Claudia Seger
Journal:  Nat Rev Genet       Date:  2011-04-19       Impact factor: 53.242

Review 4.  The Hedgehog's tale: developing strategies for targeting cancer.

Authors:  Jessica M Y Ng; Tom Curran
Journal:  Nat Rev Cancer       Date:  2011-05-26       Impact factor: 60.716

Review 5.  Review of immediate-release omeprazole for the treatment of gastric acid-related disorders.

Authors:  Donald Castell
Journal:  Expert Opin Pharmacother       Date:  2005-11       Impact factor: 3.889

6.  Identification of a potent antiandrogen that targets the BF3 site of the androgen receptor and inhibits enzalutamide-resistant prostate cancer.

Authors:  Ravi S N Munuganti; Mohamed D H Hassona; Eric Leblanc; Kate Frewin; Kriti Singh; Dennis Ma; Fuqiang Ban; Michael Hsing; Hans Adomat; Nada Lallous; Christophe Andre; Jon Paul Selvam Jonadass; Amina Zoubeidi; Robert N Young; Emma Tomlinson Guns; Paul S Rennie; Artem Cherkasov
Journal:  Chem Biol       Date:  2014-11-20

Review 7.  Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy.

Authors:  Laura Di Magno; Sonia Coni; Lucia Di Marcotullio; Gianluca Canettieri
Journal:  Biochim Biophys Acta       Date:  2015-06-12

Review 8.  Sonidegib: First Global Approval.

Authors:  Celeste B Burness
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

9.  GDC-0449-a potent inhibitor of the hedgehog pathway.

Authors:  Kirk D Robarge; Shirley A Brunton; Georgette M Castanedo; Yong Cui; Michael S Dina; Richard Goldsmith; Stephen E Gould; Oivin Guichert; Janet L Gunzner; Jason Halladay; Wei Jia; Cyrus Khojasteh; Michael F T Koehler; Karen Kotkow; Hank La; Rebecca L Lalonde; Kevin Lau; Leslie Lee; Derek Marshall; James C Marsters; Lesley J Murray; Changgeng Qian; Lee L Rubin; Laurent Salphati; Mark S Stanley; John H A Stibbard; Daniel P Sutherlin; Savita Ubhayaker; Shumei Wang; Susan Wong; Minli Xie
Journal:  Bioorg Med Chem Lett       Date:  2009-08-15       Impact factor: 2.823

10.  Targeting the binding function 3 (BF3) site of the androgen receptor through virtual screening. 2. development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole derivatives.

Authors:  Ravi Shashi Nayana Munuganti; Eric Leblanc; Peter Axerio-Cilies; Christophe Labriere; Kate Frewin; Kriti Singh; Mohamed D H Hassona; Nathan A Lack; Huifang Li; Fuqiang Ban; Emma Tomlinson Guns; Robert Young; Paul S Rennie; Artem Cherkasov
Journal:  J Med Chem       Date:  2013-01-18       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.